VaramirStart free · no cardSign in
PTGX as of Nov 2 · 09:53 ET
PTGXNasdaqPharmaceutical Preparations

Protagonist Therapeutics, Inc · Brief

Next report

3 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±9.1%
avg realized
±3.1%
Nov 7 '24±11.0%▼−2.90%×0.26
Feb 21 '25±11.7%▲+0.68%×0.06
May 6 '25±7.8%▲+2.57%×0.33
Aug 6 '25±7.0%▼−5.39%×0.77
Q3 FY25±8.9%▼−0.30%×0.03
Q1 FY26±9.0%▲+1.48%×0.16
May 5 '26±5.3%▲+4.80%×0.90
Q2 FY26±11.8%▲+6.45%×0.55
quarterimplied−15%0+15%realized×
Q2 FY26±11.8%▲+6.45%×0.55
May '26±5.3%▲+4.80%×0.90
Q1 FY26±9.0%▲+1.48%×0.16
Q3 FY25±8.9%▼−0.30%×0.03
Aug '25±7.0%▼−5.39%×0.77
May '25±7.8%▲+2.57%×0.33
2 older reports
Feb '25±11.7%▲+0.68%×0.06
Nov '24±11.0%▼−2.90%×0.26
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull1

345managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

1.07%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
26managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

PTGX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±8.4% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.